How European countries prevent and communicate on Hantavirus infection, ECDC study
Prompted by the increase of hantavirus activity in Europe observed in 2012, ECDC report reviewed the preventive measures and communication strategies in European countries.
Surveillance, prevention and control of dengue in Madeira: lessons learnt after the 2013 ECDC mission
New report provides recommendations for surveillance, prevention and control of dengue in Madeira, following the ECDC mission to Madeira in March 2013.
World Health Day 2014: focusing on vector-borne diseases in Europe
2014, the focus of World Health day was on vector-borne diseases. World Health Day is a worldwide initiative celebrated every year on 7 April to mark the anniversary of the founding of the World Health Organization (WHO) in 1948.
New ECDC protocols for surveillance of healthcare-associated infections: targeted surveillance is an essential tool for control and prevention
Today, ECDC’s Healthcare-associated Infections Surveillance Network (HAI-Net) publishes a new version of the software application HelicsWin.Net.
Viral hepatitis: testing saves lives
Every year, around 50 000 newly diagnosed cases of hepatitis B and C are reported across Europe but millions are unaware of their infection. Left untreated, hepatitis can cause irreversible liver damage. Hepatitis A is recognised as a re-emerging health threat in Europe.
World Tuberculosis Day - 24 March 2016
Marked each year on 24 March, World Tuberculosis Day gives the occasion to raise awareness about tuberculosis (TB) and to advocate more efforts to eliminate it. ECDC has launched the latest surveillance data and materials on interventions addressing vulnerable groups.
Hand Hygiene Day - SAVE LIVES: Clean Your Hands
Each year on 5 May, the “SAVE LIVES: Clean Your Hands” campaign takes place as part of a major global effort led by the World Health Organization (WHO) to improve hand hygiene in healthcare settings.
Recommendations on antivirals in European countries are appropriate, but remain underutilised in practice
Current recommendations in EU countries to use neuraminidase inhibitors (antivirals) for patients with severe influenza are supported by the available evidence, concludes a new expert opinion report from ECDC which is now open for public consultation.